ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Reversal of tetracycline resistance by clove and peony extracts in a multi-drug resistant Escherichia coli.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Infections with Gram-negative bacteria that are resistant to multiple antibiotics are increasingly prevalent and challenging to treat. We sought to identify compounds with potential to reverse resistance to tetracycline and tobramycin in a multi-drug resistant isolate of Escherichia coli (NCTC 13400). A screen of 800 extracts of traditional herbs and medicines revealed that polar extracts of cloves (Syzygium aromaticum) and Peony flowers (Paeonia lactiflora) significantly increased sensitivity to both antibiotics in this strain. Fractionation of clove and peony extracts by high performance liquid chromatography revealed activity within the fractions comprising mainly phenolic acids and flavonoids, respectively. Sampling candidate compounds from these fractions revealed that while no tested compound enhanced the activity of tobramycin, myricetin significantly increased the sensitivity of this strain to tetracycline. Myricetin alone inhibited growth, but was not bactericidal and did not induce membrane permeability or inhibit Nile red efflux. In vitro MTT assays using mammalian HEK-293 cells revealed no significant toxicity of myricetin, or most of the other tested compounds, at up to 100 µM. The results suggest that the screening of plant secondary metabolites has potential for the identification of antibiotic resistance reversers with potentially favourable in vitro toxicity profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.